DRD4 and myocardial infarction: Compared with the I/R group, DRD4 activation by PD168077 markedly decreased myocardial infarction size (Figures 2A,B), profoundly improved cardiac function, evidenced by the lower LVEDP (Figure 2C), higher +dp/dt (%) and LVDP (Figures 2D,E).